#USA #Frankfurt #risk management #Pharma Industry #Qualifyze

Introduction to Quality Insights Platform

Qualifyze, a global leader in external audit services, has taken a significant step forward in risk management for the pharmaceutical industry with its new Quality Insights Platform. Launched recently, this platform harnesses the power of artificial intelligence and is set to revolutionize how companies manage risks associated with their supply chains.

Background on the Pharmaceutical Supply Chain

In today's challenging environment, ensuring the timely availability of medications is among the greatest hurdles faced by the pharmaceutical sector. Although current tariffs on U.S. imports have provided short-term relief, the ripple effects of global economic shifts continue to heighten cost pressures. Additionally, tightening regulatory frameworks, escalating geopolitical tensions, and climate disruptions make agile risk management a necessity for pharmaceutical operations.

Quality, regulatory, and purchasing teams now grapple with immense pressure as they navigate data from various suppliers, often still relying on outdated manual processes. Such reactive measures can lead to expensive quality incidents, regulatory delays, and reputational risks, not to mention operational stress for all involved.

Presenting Quality Insights Platform

Enter Quality Insights Platform, an advanced AI-powered co-pilot designed specifically for quality and procurement professionals in the pharmaceutical sector. Utilizing Qualifyze's proprietary data from over 4,500 audits, along with information from regulatory agencies, the platform provides actionable intelligence that identifies quality risks before they materialize, expediting supplier qualification processes and fortifying supply chain resilience.

Dr. Schneider, CEO of Qualifyze, stated, "This isn’t just any tool. The Quality Insights Platform adds a level of precision that’s unparalleled, built on our extensive database of pharmaceutical audits, the largest in the world. With this solution, we achieve at least a 65% reduction in time and costs for qualifying new suppliers and proactively managing quality risks in facilities."

At the forefront of the platform's development was Almirall, one of the leading international pharmaceutical companies. Miquel Romero, Senior Director of Quality Assurance at Almirall, commented, "The platform is user-friendly and offers detailed, objective insights. Having a common platform with shareable data for sourcing conversations with the Procurement department is a genuine advantage."

Accessing Quality Insights Platform

Quality Insights Platform is available through a subscription model and does not require extensive IT infrastructure setup, making it an accessible option for organizations wanting to enhance their risk management strategies. Interested businesses can find more details and request a demonstration at qualifyze.com.

About Qualifyze

Founded in 2019, Qualifyze is a trailblazer in providing external auditing services to the life sciences sector. With its extensive pharmaceutical audit database, the company simplifies compliance, risk management, and supplier qualification based on data-driven insights. By transforming quality data into strategic foresight, Qualifyze empowers pharmaceutical companies to build trust and resilience within their supply chains.

Conclusion

In an industry marked by complexity and stringent regulations, the Quality Insights Platform offers a sophisticated means of navigating the intricacies of supply chain risks. As pharmaceutical companies continue to face mounting pressures from multiple fronts, Qualifyze is poised to be a key ally in safeguarding the integrity and reliability of essential health products.